I01 BX002619/BX/BLRD VA/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	1
2013	3
2014	4
2015	4
2016	5
2017	1
2018	3
2019	3
2020	4
2021	3
2022	1
2023	2
2024	1

1

Taylor LM, McMillan PJ, Kraemer BC, Liachko NF. Taylor LM, et al. FEBS J. 2019 Jul;286(13):2434-2446. doi: 10.1111/febs.14866. Epub 2019 May 22. FEBS J. 2019. PMID: 31034749 Free PMC article. Review.

2

Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines.

Keene CD, Darvas M, Kraemer B, Liggitt D, Sigurdson C, Ladiges W. Keene CD, et al. Pathobiol Aging Age Relat Dis. 2016 Jun 16;6:32397. doi: 10.3402/pba.v6.32397. eCollection 2016. Pathobiol Aging Age Relat Dis. 2016. PMID: 27317189 Free PMC article.

3

TDP-43/FUS in motor neuron disease: Complexity and challenges.

Guerrero EN, Wang H, Mitra J, Hegde PM, Stowell SE, Liachko NF, Kraemer BC, Garruto RM, Rao KS, Hegde ML. Guerrero EN, et al. Prog Neurobiol. 2016 Oct-Nov;145-146:78-97. doi: 10.1016/j.pneurobio.2016.09.004. Epub 2016 Sep 28. Prog Neurobiol. 2016. PMID: 27693252 Free PMC article. Review.

4

Regulation of TDP-43 phosphorylation in aging and disease.

Eck RJ, Kraemer BC, Liachko NF. Eck RJ, et al. Geroscience. 2021 Aug;43(4):1605-1614. doi: 10.1007/s11357-021-00383-5. Epub 2021 May 25. Geroscience. 2021. PMID: 34032984 Free PMC article.

5

Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.

McMillan PJ, Benbow SJ, Uhrich R, Saxton A, Baum M, Strovas T, Wheeler JM, Baker J, Liachko NF, Keene CD, Latimer CS, Kraemer BC. McMillan PJ, et al. Brain. 2023 Aug 1;146(8):3206-3220. doi: 10.1093/brain/awad032. Brain. 2023. PMID: 36732296 Free PMC article.

6

Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau.

Peskind ER, Kraemer B, Zhang J. Peskind ER, et al. JAMA Neurol. 2015 Oct;72(10):1103-5. doi: 10.1001/jamaneurol.2015.1789. JAMA Neurol. 2015. PMID: 26237033 No abstract available.

7

DOPA Decarboxylase Modulates Tau Toxicity.

Kow RL, Sikkema C, Wheeler JM, Wilkinson CW, Kraemer BC. Kow RL, et al. Biol Psychiatry. 2018 Mar 1;83(5):438-446. doi: 10.1016/j.biopsych.2017.06.007. Epub 2017 Jun 15. Biol Psychiatry. 2018. PMID: 28751068 Free PMC article.

8

Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration.

Kow RL, Black AH, Saxton AD, Liachko NF, Kraemer BC. Kow RL, et al. Geroscience. 2022 Apr;44(2):747-761. doi: 10.1007/s11357-022-00526-2. Epub 2022 Feb 4. Geroscience. 2022. PMID: 35122183 Free PMC article.

9

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Eck RJ, Stair JG, Kraemer BC, Liachko NF. Eck RJ, et al. Front Neurosci. 2024 Jan 4;17:1300705. doi: 10.3389/fnins.2023.1300705. eCollection 2023. Front Neurosci. 2024. PMID: 38239833 Free PMC article. Review.

10

Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA-Protein Interaction.

Baker JD, Uhrich RL, Strovas TJ, Saxton AD, Kraemer BC. Baker JD, et al. ACS Chem Neurosci. 2020 Aug 5;11(15):2277-2285. doi: 10.1021/acschemneuro.0c00214. Epub 2020 Jul 9. ACS Chem Neurosci. 2020. PMID: 32589834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year